Zhuang et al. demonstrated in a different cohort study that high MALAT1 expression was an important predictor of prognosis in CRC patients with recurrence (P = 0.0167) and had no predictive value for prognosis in patients without recurrence [22]. Here, MALAT1 is linked to colorectal carcinoma.